If you are not happy with the results, please do another search

Initial Public Offering of Fujiyama Power Systems Limited

JSA is advising Fujiyama Power Systems Limited, a manufacturer of products and a solution provider in the roof-top solar industry (including solar panels, inverters and batteries), in relation to its proposed initial public offering (the “IPO“) comprising a fresh issue of up to INR 7,000.00 million and an offer for sale of up to 20,000,000 equity shares by certain promoters. Motilal Oswal Investment Advisors Limited and SBI Capital Markets Limited are acting as the book running lead managers for the IPO.

Our Transaction Team Comprised Partners – Madhurima Mukherjee Saha and Anuj Pethia, Senior Associate – Ambuj Gupta, and Associates – Harshita AgarwalKumar Shubham, and Priyanshi Bajaj.

Initial Public Offering of Senores Pharmaceuticals Limited

JSA advised Equirus Capital Private Limited, Ambit Private Limited and Nuvama Wealth Management Limited (the book running lead managers) in relation to the initial public offering of equity shares of Senores Pharmaceuticals Limited (“Company”) aggregating to ₹ 5,821.10 million comprising a fresh issue of ₹ 5,000 million and an offer for sale of ₹ 821.10 million by certain selling shareholders of the Company.

Our Transaction Team Comprised Lead Partner – Arka Mookerjee, Partner – Siddhartha Desai, and Associate – Govind Roy, Anvita Sinha and Prateek Khandelwal.

Proposed Rights Issue by Fusion Finance

JSA is advising IIFL Capital Services Limited, the book-running lead manager, on the proposed rights issue of partly paid equity shares by Fusion Finance Limited(the “Issuer”). The Issuer is planning a rights issue of up to ₹800 crores and has filed a draft letter of offer with SEBI.

Our Transaction Team Comprised Partners – Madhurima Mukherjee Saha, and Anuj Pethia, Associates – Anshuman Singh, Bhavini Mohan, and Kumar Shubham.

Initial Public Offering of Unimech Aerospace and Manufacturing Limited

JSA advised Anand Rathi Advisors Limited and Equirus Capital Private Limited, the book running lead managers in relation to the initial public offering of equity shares of Unimech Aerospace and Manufacturing Limited (“Company“) comprising a fresh issue of ₹ 2,500 million and offer for sale by certain shareholders of the Company of 31,84,713 equity shares aggregating to ₹ 2,500.00 million.

Our Transaction Team Comprised Lead Partner – Arka Mookerjee, Partners – Pracheta Bhattacharya, Anshu Bansal and Associates – Aditi Khandal, Ayushi Pandit, Ankesh Kumar, Dhvanit Kothari, Nikhil Panchal, and Vaishnavi Kokkonda.

Qualified Institutions Placement of Senco Gold Limited

JSA advised Senco Gold Limited (“Senco”) regarding its qualified institutions placement (“QIP”) of 4,080,000 equity shares to qualified institutional buyers aggregating to ₹ 4,590 million. Ambit Private Limited and Emkay Global Financial Services Limited were the book-running lead managers to the QIP. JSA also advised Senco on its IPO last year.

Our Transaction Team Comprised Lead Partner – Arka Mookerjee, Partner – Pracheta Bhattacharya, Senior Associate – Sourav Modi, and Associates – Vatsla Varandani, Ritu R Jaiswal, Palak Karundia.

Initial Public Offering of Transrail Lighting Limited

JSA advised Inga Ventures Private Limited, Axis Capital Limited, HDFC Bank Limited and IDBI Capital Markets & Securities Limited in relation to the initial public offering of equity shares of Transrail Lighting Limited aggregating to ₹8,389.12 million (“IPO”).

Transrail Lighting Limtied is an Indian engineering, procurement and construction (“EPC”) company, primarily focussing on power transmission and distribution business and integrated manufacturing facilities for lattice structures, conductors, and monopoles.

Our Transaction Team Comprised Lead Partner – Arka Mookerjee, Partner – Pracheta Bhattacharya, and Associates – Govind Roy and Anvita Sinha.

Initial Public Offering of Suraksha Diagnostic Limited

JSA advised ICICI Securities Limited, Nuvama Wealth Management Limitedand SBI Capital Markets Limited in relation to the initial public offering of equity shares of Suraksha Diagnostic Limited aggregating to ₹8,462.49 million (“IPO”), comprising of an offer for sale by OrbiMed Asia II Mauritius Limited, Dr. Somnath Chatterjee, Ritu Mittal, Satish Kumar Verma, Munna Lal Kejriwal and Santosh Kumar Kejriwal.

Suraksha Diagnostic Limited offers one-stop integrated solutions for pathology and radiology testing and medical consultation services through their operational network consisting of a central reference laboratory, satellite laboratories, diagnostic centres, and sample collection centres.

Our Transaction Team Comprised Lead Partner – Arka Mookerjee, Partner – Pracheta Bhattacharya, Senior Associate – Sourav Modi, and Associates – Dhvanit Kothari, Jeebitesh Bhattacharya, Ankesh Kumar, and Junior Associate – Anoop Mukundan.